Human Microbiome Market :North America and Europe Will Command a Large Combined Chunk of the Revenue
Globally, there is an expanding base of patients suffering from lifestyle diseases, autoimmune disorders, and chronic diseases, such as obesity, diabetes, and cancer. The growing preference for human microbiome-based therapies in the treatment of these diseases is providing a fillip to the market.
View full press release